Pfizer Inc.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, LLY.DE has a market cap of 639.2B. Regarding current trading prices, PFE.DE is priced at €20.62, while LLY.DE trades at €674.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas LLY.DE's P/E ratio is 62.91. In terms of profitability, PFE.DE's ROE is +0.09%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, PFE.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, JNJ.DE has a market cap of 326.8B. Regarding current trading prices, PFE.DE is priced at €20.62, while JNJ.DE trades at €135.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas JNJ.DE's P/E ratio is 17.30. In terms of profitability, PFE.DE's ROE is +0.09%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, PFE.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, 4AB.DE has a market cap of 295.3B. Regarding current trading prices, PFE.DE is priced at €20.62, while 4AB.DE trades at €167.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas 4AB.DE's P/E ratio is 81.56. In terms of profitability, PFE.DE's ROE is +0.09%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, PFE.DE is more volatile compared to 4AB.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, ZEG.DE has a market cap of 198.4B. Regarding current trading prices, PFE.DE is priced at €20.62, while ZEG.DE trades at €127.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas ZEG.DE's P/E ratio is 29.41. In terms of profitability, PFE.DE's ROE is +0.09%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, PFE.DE is more volatile compared to ZEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, 6MK.DE has a market cap of 174.5B. Regarding current trading prices, PFE.DE is priced at €20.62, while 6MK.DE trades at €69.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas 6MK.DE's P/E ratio is 11.51. In terms of profitability, PFE.DE's ROE is +0.09%, compared to 6MK.DE's ROE of +0.38%. Regarding short-term risk, PFE.DE is less volatile compared to 6MK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, AMG.DE has a market cap of 137.2B. Regarding current trading prices, PFE.DE is priced at €20.62, while AMG.DE trades at €255.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas AMG.DE's P/E ratio is 26.58. In terms of profitability, PFE.DE's ROE is +0.09%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, PFE.DE is more volatile compared to AMG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, GIS.DE has a market cap of 121.8B. Regarding current trading prices, PFE.DE is priced at €20.62, while GIS.DE trades at €97.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas GIS.DE's P/E ratio is 23.53. In terms of profitability, PFE.DE's ROE is +0.09%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, PFE.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, PFE.F has a market cap of 117.1B. Regarding current trading prices, PFE.DE is priced at €20.62, while PFE.F trades at €20.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas PFE.F's P/E ratio is 17.16. In terms of profitability, PFE.DE's ROE is +0.09%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, PFE.DE and PFE.F have similar daily volatility (2.13).

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, SNW.DE has a market cap of 107.7B. Regarding current trading prices, PFE.DE is priced at €20.62, while SNW.DE trades at €88.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas SNW.DE's P/E ratio is 17.72. In terms of profitability, PFE.DE's ROE is +0.09%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, PFE.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, BRM.DE has a market cap of 86.4B. Regarding current trading prices, PFE.DE is priced at €20.62, while BRM.DE trades at €42.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas BRM.DE's P/E ratio is 18.06. In terms of profitability, PFE.DE's ROE is +0.09%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, PFE.DE is more volatile compared to BRM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, BAYN.SG has a market cap of 26B. Regarding current trading prices, PFE.DE is priced at €20.62, while BAYN.SG trades at €26.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, PFE.DE's ROE is +0.09%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, PFE.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, BAYN.DE has a market cap of 26B. Regarding current trading prices, PFE.DE is priced at €20.62, while BAYN.DE trades at €26.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas BAYN.DE's P/E ratio is -7.96. In terms of profitability, PFE.DE's ROE is +0.09%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, PFE.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, IDP.DE has a market cap of 17.1B. Regarding current trading prices, PFE.DE is priced at €20.62, while IDP.DE trades at €116.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas IDP.DE's P/E ratio is 13.09. In terms of profitability, PFE.DE's ROE is +0.09%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, PFE.DE is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.DE.

PFE.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.DE stands at 117.2B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, PFE.DE is priced at €20.62, while GS7.DE trades at €20.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.DE currently has a P/E ratio of 17.04, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, PFE.DE's ROE is +0.09%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, PFE.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.DE.